Related Experiment Video
Updated: Jan 17, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Toward a Clinically Actionable, Electronic Health Record-Based Machine Learning Model to Forecast 90-Day Change in
Erin M Tallon1,2,3, David D Williams4, Cintya Schweisberger1,2
1Division of Pediatric Endocrinology and Diabetes, Children's Mercy Kansas City, 2401 Gillham Road, Kansas City, MO, United States, 1 8166014023.
This study developed a machine learning model using electronic health records to predict glycemic deterioration in youth with type 1 diabetes (T1D), enabling earlier intervention for better health outcomes.
Area of Science:
- Pediatric Endocrinology
- Data Science in Healthcare
- Clinical Informatics
Background:
- Clinicians need tools to identify youth with type 1 diabetes (T1D) at risk of worsening glycemic control between visits.
- Current methods are insufficient for proactive intervention, limiting care for rising HbA1c levels.
Purpose of the Study:
- To assess the feasibility of using electronic health record (EHR) data to build a machine learning (ML) model.
- To predict 90-day changes in HbA1c in youth (9-18 years) with T1D.
- To enhance clinical decision-making by identifying youth with clinically significant HbA1c increases.
Main Methods:
- Utilized longitudinal EHR data from 1743 youth with T1D (2012-2017).
- Transformed over 17,000 features from EHR data for model training.
- Employed random forest regression with 3-fold cross-validation to predict HbA1c unit-change.
Main Results:
- The ML model demonstrated strong correlation between predicted and actual HbA1c (r=0.79).
- Key predictors included postal code, HbA1c metrics, and treatment engagement difficulty.
- At a ≥0.3% HbA1c rise threshold, the model achieved 60.3% positive predictive value, a 1.5-fold enrichment.
Conclusions:
- Routinely collected EHR data can effectively train ML models to predict HbA1c changes in youth with T1D.
- This predictive capability can aid in timely interventions to manage glycemic control.
- Future research will focus on model optimization and validation in diverse cohorts.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
